Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / IMRN - Immuron +8% on Travelers' Diarrhea update


IMRN - Immuron +8% on Travelers' Diarrhea update

Immuron (IMRN) to recommence CMC related activities regarding its investigational drug IMM-124E, required for study of Travelers' Diarrhea or TDUniformed Services University recommended planned clinical trial program to evaluate the efficacy of non-antibiotic OTC products in TD and will provide a purchase order for IMM-124E.The company has executed a consultancy agreement with Professor Teena Chopra, Professor of Medicine at Wayne State University School of Medicine in Detroit, Michigan.Stock +8% PMPress Release

For further details see:

Immuron +8% on Travelers' Diarrhea update
Stock Information

Company Name: Immuron Limited
Stock Symbol: IMRN
Market: NASDAQ
Website: immuron.com.au

Menu

IMRN IMRN Quote IMRN Short IMRN News IMRN Articles IMRN Message Board
Get IMRN Alerts

News, Short Squeeze, Breakout and More Instantly...